Dalbavancin hydrochloride | Interleukin Related interleukin-related.com

Product Name :
Dalbavancin hydrochloride

Search keywords :
Dalbavancin

drugId :
null

Target Vo:
Peptidoglycan

Target Vo Short Name :
Peptidoglycan

Moa_Name:
Peptidoglycan inhibitors

First Approval Country :
United States

First Approval Date Filter:
2014

Origin Company_Name :
Actavis

Active Company_Name :
Abbvie Deutschland Gmbh & Co Kg

Active Indication_Name:
Acute bacterial skin and skin structure infections

In Active Indication_Name:
Cellulitis

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Histone H3 (tri methyl K9) Mouse mAb In stock
Ixekizumab Immunology/Inflammation
JNK1 Antibody (YA720): JNK1 (1A4) Antibody is a non-conjugated and Mouse origined monoclonal antibody about 48 kDa, targeting to JNK1 (1A4). It can be used for WB,ICC/IF assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts